Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.

Axel MuendleinChristine HeinzleEva Maria BrandtnerAndreas LeihererKathrin GeigerStella GaengerHeinz DrexelTobias DechowThomas Decker

Published in: Breast cancer research and treatment (2023)

Our study suggests that circulating APOM is significantly linked with reduced mortality in metastatic breast cancer patients.

Keyphrases